Publications by authors named "Ruth Duncan"

Claim this Profile
B
Bridging the gap in trauma care across New Zealand.
Luke Barker, Ruth Duncan, James McKay, Christopher Wakeman

N Z Med J· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of major trauma admissions to Christchurch Hospital during and after COVID-19 lockdown in New Zealand.
Dali Fan, Hannah Scowcroft, Andrew McCombie, Ruth Duncan, Christopher Wakeman

N Z Med J· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymer therapeutics at a crossroads? Finding the path for improved translation in the twenty-first century.
Ruth Duncan

J Drug Target· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymer therapeutics: Top 10 selling pharmaceuticals - what next?
Ruth Duncan

J Control Release· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2. Commentary on dendrimers: why dendrimers?: Original research article: Relationship between structure and biocompatibility in vitro preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers (2000).
Ruth Duncan

J Control Release· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of tumour models for use in anticancer nanomedicine evaluation: the EPR effect and cathepsin B-mediated drug release rate.
Ruth Duncan, Yee-Nee Sat-Klopsch, Angelika M Burger, Michael C Bibby, Heinz H Fiebig

Cancer Chemother Pharmacol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next-generation nanomedicines and nanosimilars: EU regulators' initiatives relating to the development and evaluation of nanomedicines.
Falk Ehmann, Kumiko Sakai-Kato, Ruth Duncan, Dolores Hernán Pérez de la Ossa, Ruben Pita

Nanomedicine (Lond)· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymer therapeutics-prospects for 21st century: the end of the beginning.
Ruth Duncan, María J Vicent

Adv Drug Deliv Rev· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endocytosis and intracellular trafficking as gateways for nanomedicine delivery: opportunities and challenges.
Ruth Duncan, Simon C W Richardson

Mol Pharm· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanomedicine(s) under the microscope.
Ruth Duncan, Rogerio Gaspar

Mol Pharm· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymer therapeutics as nanomedicines: new perspectives.
Ruth Duncan

Curr Opin Biotechnol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of dextrin-rhEGF on the healing of full-thickness, excisional wounds in the (db/db) diabetic mouse.
Joseph T Hardwicke, Jeff Hart, Andrea Bell, Ruth Duncan, David W Thomas

J Control Release· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of polymer tacticity on the physico-chemical behaviour of polymers proposed as therapeutics.
Lorella Izzo, Peter C Griffiths, Renuka Nilmini, Stephen M King, Kerri-Lee Wallom, Ruth Duncan

Int J Pharm· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymer coiled-coil conjugates: potential for development as a new class of therapeutic "molecular switch".
Samuel P E Deacon, Bojana Apostolovic, Rodrigo J Carbajo, Anne-Kathrin Schott, Konrad Beck, Ruth Duncan

Biomacromolecules· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell uptake and trafficking behavior of non-covalent, coiled-coil based polymer-drug conjugates.
Bojana Apostolovic, Samuel P E Deacon, Ruth Duncan, Harm-Anton Klok

Macromol Rapid Commun· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interaction of an endosomolytic polyamidoamine ISA23 with vesicles mimicking intracellular membranes: A SANS/EPR study.
Peter C Griffiths, Renuka Nilmini, Emma Carter, Patrick Dodds, Damien M Murphy, Ruth Duncan

Macromol Biosci· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioresponsive dextrin-rhEGF conjugates: in vitro evaluation in models relevant to its proposed use as a treatment for chronic wounds.
Joseph Hardwicke, Ryan Moseley, Phil Stephens, Keith Harding, Ruth Duncan

Mol Pharm· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hybrid polymer therapeutics incorporating bioresponsive, coiled coil peptide linkers.
Bojana Apostolovic, Samuel P E Deacon, Ruth Duncan, Harm-Anton Klok

Biomacromolecules· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Studies on the mechanism of action of dextrin-phospholipase A2 and its suitability for use in combination therapy.
Elaine L Ferguson, Simon C W Richardson, Ruth Duncan

Mol Pharm· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intracellular fate of bioresponsive poly(amidoamine)s in vitro and in vivo.
Simon C W Richardson, Nicola G Pattrick, Nathalie Lavignac, Paolo Ferruti, Ruth Duncan

J Control Release· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do HPMA copolymer conjugates have a future as clinically useful nanomedicines? A critical overview of current status and future opportunities.
Ruth Duncan, María J Vicent

Adv Drug Deliv Rev· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymeric carriers: preclinical safety and the regulatory implications for design and development of polymer therapeutics.
Rogério Gaspar, Ruth Duncan

Adv Drug Deliv Rev· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymer therapeutics: clinical applications and challenges for development.
María J Vicent, Helmut Ringsdorf, Ruth Duncan

Adv Drug Deliv Rev· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of HPMA copolymer-anticancer conjugates: clinical experience and lessons learnt.
Ruth Duncan

Adv Drug Deliv Rev· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Approaches for quantifying and managing diffuse phosphorus exports at the farm/small catchment scale.
Richard W McDowell, David Nash, Anja George, Q J Wang, Ruth Duncan

J Environ Qual· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis